Founder and CEO
Susan founded The NemetzGroup in late 2003 to help clients balance the entrepreneurial spirit of breakthrough innovations with the need for discipline and process to achieve the maximum potential of their technology, team, and company. In 2018, she built upon her history of innovating for biopharma companies by founding Corval, a SaaS platform that enables early- to mid-stage companies to free themselves from the fragmented commercialization planning process and create a strategic roadmap that is completely aligned with the company, product, and vision. Today, Susan serves as CEO of both The NemetzGroup and Corval. Susan has spent over three decades as a senior executive working in the life sciences sector. Her industry accomplishments are many and include creating international operating strategies for the launch of a novel cancer therapy and successfully integrating two distinct therapeutic and imaging organizations into a cohesive cardiovascular franchise. Her commitment to mentoring the next generation of leaders is apparent in her commitment to clients and hands-on leadership of The NemetzGroup and Corval.
In early 2012, Marnie joined The NemetzGroup contributing more than two decades of pharmaceutical and biotechnology executive level experience in corporate strategy, market research, new product planning, and business development to our team and clients. Marnie is adept at creating a marketable commercial story as well as developing intricate forecast models for clients. She has versatility across a number of industry disciplines and therapeutic areas and the ability to help teams excel. Marnie earned a Bachelor of Science in Marketing and an MBA in Entrepreneurial Business and Finance.
Colleen brings considerable senior experience in marketing, strategy development, operations, and project management within the life sciences and high-tech industries. Colleen’s keen analytical skills, collaborative problem solving approach, and comprehensive exposure across therapeutic areas enable an interdisciplinary approach to the key questions of commercial and brand strategy. In addition, her expertise in commercialization mapping assists companies at all stages. Colleen received her Bachelor of Science in Finance and holds an MBA. She joined The NemetzGroup in 2005.
Lori has several years of industry experience in oncology and global marketing, and has successfully launched many drugs. She recently joined The NemetzGroup from a global executive role at a commercial stage biotech company. Her expertise includes new product planning, life cycle management, brand strategy and execution, business development, and asset valuation. Lori is a highly effective leader with skills that range the commercialization spectrum. Lori holds a Bachelor of Science in Ocean Engineering, a Master of Science in Administration, and an MBA.
Meighan's fifteen plus years of industry experience includes new product planning, commercial assessment, business development, and global marketing strategy at a leading pharmaceutical company. She understands how to work with teams across the spectrum from clinical to market access to lifecycle management, both domestically and globally. In a recent engagement, she led a launch initiative for an oncology therapy and has played a key integrator role on a scientific affairs team focused on anti-infectives. Meighan's undergraduate degree is in Law and Public Policy. She also holds a Master of Library and Information Science. Meighan joined The NemetzGroup in 2015.
Jim's broad industry and consulting background over twenty-five years includes product development strategy, new product and lifecycle planning, global product launches, and market analysis. Jim partners with clients ranging from emerging companies to global pharmaceutical firms, providing commercial strategy, brand planning, and market research support. His considerable knowledge of oncology, orphan diseases, and specialty markets plus his ability to facilitate engaging workshops has made Jim a valued asset for our clients since he joined in 2011. Jim has an undergraduate degree in Biological Science with a minor in Chemistry.
Marianne has over twenty years of industry experience with expertise across a range of sales, marketing, and commercial operations at top pharmaceutical companies, involving numerous therapeutic areas including oncology, virology, and respiratory disease.
With a collaborative style and focus on results, she is skilled at bringing cross-functional teams together and directing the effort through the critical phases of commercialization, including launch strategy, tactical planning and execution, and field deployment. Most recently, Marianne was instrumental in helping two emerging biotech companies through successful high-profile inaugural product launches.
Marianne holds a Bachelor of Science degree in Business Administration, is a long-time member of Healthcare Businesswomen’s Association, and spends time lending a hand to healthcare-related social benefit organizations.
Ray joins The NemetzGroup as an enthusiastic and strategic medical affairs leader with a 13-year career spanning big pharma and small biotech in US- and Global-focused roles. Ray began his career at BMS and has subsequently led the development of strategic medical affairs plans and activities for launches of multiple therapies to treat both rare and common conditions, utilizing his therapeutic area expertise in oncology, rare disease, pediatrics, and neuropsychiatry. As part of his training and within the pharmaceutical industry, he has hands-on interventional and observational research experience and successful engagements with health authorities and health technology assessors. Most recently, Ray built two medical affairs organizations from the ground up, establishing and overseeing multiple critical functions including medical/scientific communications, key opinion leader engagement and field medical science liaisons (MSLs), health economics and outcomes research, preapproval access programs, investigator initiated studies, and medical information. Ray received his MD from Tufts University School of Medicine and his PhD in Genetics from the Tufts School of Graduate Biomedical Sciences.
Kristin joins The NemetzGroup as an accomplished, results-oriented, and strategic commercial leader with almost two decades of diverse pharmaceutical experience. Her expertise includes sales, operations, lifecycle management, brand strategy and execution, and business development. She has US and global experience across numerous therapeutic areas in both broad spectrum and rare diseases. She has managed portfolios from launch through authorized generics and appreciates the need for a long-term, proactive approach to lifecycle management. Kristin is a hands-on team leader and inspiring motivator with excellent analytical, problem-solving, and communication skills. She holds a BA in Economics from Boston College and an MBA in Finance from Villanova University. She joined The NemetzGroup in 2020.
Liz brings over ten years of professional marketing experience to The NemetzGroup in her work with classic and digital communications firms whose life science clients straddle both the provider and manufacturer worlds. She joined The NemetzGroup in 2014 and has managed both strategic and tactical initiatives for clients including market research, brand planning, commercial mapping, messaging, and sales tool development. Liz is highly valued by clients for her ability to help them focus on critical priorities so that they can achieve their leadership objectives often including role definition and team operating principles. Liz holds a Bachelor of Science in Communications as well as an MBA.
Cindy is a senior finance professional with experience creating financial, operational, and administrative structures critical to the growth of small companies. She has expertise advising companies on acquisitions, divestitures, shareholder value, and capital structure in the consumer product and retail industries. Following a Wall Street career that included three years in Belgium, Cindy has developed and directed organizational functions such as accounting, forecasting, benefits, payroll, and human resource policies for growing consultancy firms. She joined The NemetzGroup in 2012 and holds a Bachelor of Arts degree in Economics.
Donna joined the NemetzGroup in 2017 after spending 15 years organizing and maintaining the business for a Financial Advisor. Prior experience includes working in the finance department of a manufacturing company responsible for accounts payable, accounts receivable, and payroll. As Finance and Operations Manager, Donna assists the finance and accounting team while also supporting The NemetzGroup on various internal and external client projects. Her positive, can-do spirit and ability to work cross-functionally makes her a strong team member. Donna received a Paralegal Degree and an Accounting Certificate.
Ellen brings to The NemetzGroup three decades of commercial experience in brand strategy, product launch planning and execution, medical education, and senior leadership with biotechnology and specialty pharmaceutical companies. She has created and driven strategic business plans spanning multiple therapeutic areas and developed high-performing teams to consistently achieve positive financial results. Ellen has contributed her organizational build, planning and commercialization skills to The NemetzGroup since 2013. Earning a Bachelor of Arts degree in Nursing, her early career as a registered nurse at an urban trauma center provided a strong clinical and patient-centered foundation.